Tekla Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-37,700
| Closed | -$561K | – | 204 |
|
|
2019
Q2 | $561K | Sell |
37,700
-37,700
| -50% | -$561K | 0.02% | 181 |
|
|
2019
Q1 | $1.87M | Hold |
75,400
| – | – | 0.08% | 134 |
|
|
2018
Q4 | $1.35M | Hold |
75,400
| – | – | 0.06% | 146 |
|
|
2018
Q3 | $2.21M | Hold |
75,400
| – | – | 0.08% | 147 |
|
|
2018
Q2 | $3.43M | Hold |
75,400
| – | – | 0.13% | 108 |
|
|
2018
Q1 | $3.98M | Hold |
75,400
| – | – | 0.15% | 102 |
|
|
2017
Q4 | $5.13M | Hold |
75,400
| – | – | 0.2% | 89 |
|
|
2017
Q3 | $6.21M | Sell |
75,400
-75,400
| -50% | -$6.21M | 0.22% | 78 |
|
|
2017
Q2 | $14.1M | Buy |
+150,800
| New | +$14.1M | 0.52% | 41 |
|
|
2015
Q1 | – | Sell |
-51
| Closed | -$3K | – | 107 |
|
|
2014
Q4 | $3K | Sell |
51
-104,000
| -100% | -$6.12M | ﹤0.01% | 92 |
|
|
2014
Q3 | $4.72M | Buy |
104,051
+56,687
| +120% | +$2.57M | 0.22% | 76 |
|
|
2014
Q2 | $1.96M | Hold |
47,364
| – | – | 0.18% | 57 |
|
|
2014
Q1 | $3.28M | Buy |
47,364
+14,706
| +45% | +$1.02M | 0.33% | 51 |
|
|
2013
Q4 | $1.97M | Buy |
32,658
+9,971
| +44% | +$601K | 0.21% | 48 |
|
|
2013
Q3 | $1.38M | Buy |
+22,687
| New | +$1.38M | 0.15% | 58 |
|